Metamizole and risk of agranulocytosisFirst published 27/08/2021 Last updated 17/06/2024 EU PAS number: EUPAS41314StudyFinalised
Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Medical Devices, AEMPS)Spain First published: 01/02/2024Last updated 01/07/2024 InstitutionEU Institution/Body/AgencyNot-for-profitRegulatory Authority